GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Genomic Valley Biotech Ltd

Genomic Valley Biotech Board to Review Q2 FY27 Unaudited Financial Results

BOARD ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 21 Oct 2026, 01:01 PM IST  ·  BSE ID: f08cf71c-6ad6-49fb-983d-e562f253d7d4
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors will meet soon to review and approve the latest financial performance numbers for the past three and six months.
🤖 AI Summary
  • Board meeting scheduled for October 30, 2026, to approve unaudited financial results.
  • Focus on the quarter and half-year period ending September 30, 2026.
  • Trading window closed from October 1, 2026, until results are public.
  • No other specific agenda items were detailed beyond financial review.
🏢 How This Affects the Company
💰
Financial Impact
The meeting will confirm the unaudited financial results for the quarter and half-year ended September 30, 2026, providing an update on the company's financial performance.
⚠️
Risk Impact
The closure of the trading window prevents insider trading ahead of the financial results announcement, a standard regulatory practice.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time. Shareholders should await the release of the financial results.
👤
Who Is Affected
All shareholders are affected as they will receive the unaudited financial results for the period ending September 30, 2026.
🔍
Management Signal
Management is adhering to standard corporate governance and disclosure norms by scheduling a board meeting to review financials.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting on October 30, 2026, for financial results approval.
Publication of unaudited financial results for Q2 and H1 FY27.
Reopening of the trading window 48 hours after results disclosure.
LOW RISK The filing is a routine procedural announcement for a board meeting to review financial results.
💡 Investor Takeaway
Genomic Valley Biotech's Board of Directors will convene on October 30, 2026, to review and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
❓ Frequently Asked Questions
When will Genomic Valley Biotech's board meet to approve financial results?
Genomic Valley Biotech's Board of Directors will meet on Friday, October 30, 2026, to consider and approve unaudited financial results.
What period do the upcoming financial results for Genomic Valley Biotech cover?
The upcoming financial results will cover the quarter and half-year ended September 30, 2026.
When does the trading window close for Genomic Valley Biotech securities?
The trading window for dealing in Genomic Valley Biotech securities is closed from October 1, 2026, until 48 hours after the results are made public.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.